B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC. · Pharmaceutical research and manufacturing company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Issues related to drug pricing. Public Law 119-21: One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.